Latest Articles
Postpartum Colic: Could Gut Flora Serve As Early Warning? - MSN
Postpartum Colic: Could Gut Flora Serve As Early Warning? MSN
Published: Nov. 21, 2024, 4:52 a.m.
Florence Pugh on PCOS, Endometriosis, Egg Freezing, and Navigating Body Image in Hollywood - SHE MD - iHeartRadio
Florence Pugh on PCOS, Endometriosis, Egg Freezing, and Navigating Body Image in Hollywood - SHE MD iHeartRadio
Published: Nov. 19, 2024, 6:44 p.m.
Florence Pugh Reveals 'Mind-Boggling Realization' She Had At 27 - iHeartRadio
Florence Pugh Reveals 'Mind-Boggling Realization' She Had At 27 iHeartRadio
Published: Nov. 19, 2024, 6:44 p.m.
Kerry Katona unable to move as she shares chronic health condition 'like being ripped apart' - MSN
Kerry Katona unable to move as she shares chronic health condition 'like being ripped apart' MSN
Published: Nov. 17, 2024, 11:28 a.m.
Kerry Katona unable to move as she shares chronic health condition 'like being ripped apart' - Birmingham Live
Kerry Katona unable to move as she shares chronic health condition 'like being ripped apart' Birmingham Live
Published: Nov. 16, 2024, 9:44 p.m.
Kelly O’Brien shares her life as a Dolly Parton doppelganger - Now To Love
Kelly O’Brien shares her life as a Dolly Parton doppelganger Now To Love
Published: Nov. 16, 2024, 6 p.m.
AIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times
AIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate Update The Manila Times
Published: Nov. 15, 2024, 12:56 p.m.
AIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
AIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire
Published: Nov. 15, 2024, 12:30 p.m.
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 - The Malaysian Reserve
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 The Malaysian Reserve
Published: Nov. 14, 2024, 11:05 p.m.
Lisata Therapeutics CEO David Mazzo on Q3 results; updates on key clinical trials and partnerships - Proactive Investors UK
Lisata Therapeutics CEO David Mazzo on Q3 results; updates on key clinical trials and partnerships Proactive Investors UK
Published: Nov. 14, 2024, 4:39 p.m.
Link copied to clipboard!